13th November 2019
- 0 comments
Foresight Group has made a £3 million investment into Biotherapy Services Limited, a biopharmaceutical company specialising in regenerative medicine for the treatment of complex wounds. One of its products is currently undergoing a clinical trial for treating chronic diabetic foot ulcers (DFUs).
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage